These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6442061

  • 1. [Kidney tubular injury in the use of sodium aurothiomalate and its detection by determination of urinary beta-2-microglobulin].
    Ulreich A, Rainer F, Sedlmayr DP, Leb G, Pfeiffer K.
    Wien Klin Wochenschr Suppl; 1984; 156():56-7. PubMed ID: 6442061
    [No Abstract] [Full Text] [Related]

  • 2. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E, Lehtinen K, Isomäki H, Nissilä M, Harmoinen A, Mörsky P, Koivula T, Vapaatalo H.
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [Abstract] [Full Text] [Related]

  • 3. Measurement of urinary beta 2-microglobulin in the detection of cisplatin nephrotoxicity.
    Cohen AI, Harberg J, Citrin DL.
    Cancer Treat Rep; 1981; 65(11-12):1083-5. PubMed ID: 6170429
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Letter: Gold nephropathy and glucocorticoids.
    Szabo S.
    Arch Pathol; 1974 Jul; 98(1):66. PubMed ID: 4208400
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.
    Latt D, Weiss JB, Jayson MI.
    Ann Rheum Dis; 1981 Apr; 40(2):157-60. PubMed ID: 6164344
    [Abstract] [Full Text] [Related]

  • 10. [A case with gold nephropathy: X-ray energy dispersive analysis of gold deposition in renal tissue (author's transl)].
    Kaizu K, Maruoka K, Oda E, Oda S, Ono A, Okazaki I, Chiba S, Eto S, Suzuki H.
    Nihon Naika Gakkai Zasshi; 1982 Mar 10; 71(3):364-72. PubMed ID: 6809867
    [No Abstract] [Full Text] [Related]

  • 11. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
    Rodríguez Pérez M, González Domínguez J, Matarán Pérez L, Salvatierra Ríos D.
    An Med Interna; 1993 Oct 10; 10(10):484-6. PubMed ID: 8136425
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary gold toxicity.
    Morley TF, Komansky HJ, Adelizzi RA, Giudice JC.
    Eur J Respir Dis; 1984 Nov 10; 65(8):627-32. PubMed ID: 6440806
    [Abstract] [Full Text] [Related]

  • 14. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H.
    J Rheumatol Suppl; 1982 Nov 10; 8():184-9. PubMed ID: 6813483
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypothesis for the pathogenesis of sodium aurothiomalate (Myocrisin) induced immune complex nephritis.
    Skrifvars B.
    Scand J Rheumatol; 1979 Nov 10; 8(2):113-8. PubMed ID: 156394
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Another anaphylactic reaction after gold (aurothiomalate) injection.
    Neustadt DH.
    J Rheumatol; 1995 Jan 10; 22(1):190. PubMed ID: 7699674
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.